cp 93129 has been researched along with 5,7-dihydroxytryptamine in 2 studies
Studies (cp 93129) | Trials (cp 93129) | Recent Studies (post-2010) (cp 93129) | Studies (5,7-dihydroxytryptamine) | Trials (5,7-dihydroxytryptamine) | Recent Studies (post-2010) (5,7-dihydroxytryptamine) |
---|---|---|---|---|---|
109 | 0 | 11 | 1,278 | 0 | 55 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birthelmer, A; Cassel, JC; Jackisch, R; Jeltsch, H; Schweizer, T | 1 |
Amtage, F; Birthelmer, A; Cassel, JC; Ehret, A; Förster, S; Jackisch, R; Jeltsch, H; Lehmann, O | 1 |
2 other study(ies) available for cp 93129 and 5,7-dihydroxytryptamine
Article | Year |
---|---|
5,7-Dihydroxytryptamine lesions enhance and serotonergic grafts normalize the evoked overflow of acetylcholine in rat hippocampal slices.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Animals; Choline; Chromatography, High Pressure Liquid; Hippocampus; Injections, Intraventricular; Male; Methiothepin; Neurons; Pyridines; Pyrroles; Raphe Nuclei; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2002 |
Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Adrenergic alpha-Agonists; Animals; Antibodies, Monoclonal; Biogenic Monoamines; Brimonidine Tartrate; Choline O-Acetyltransferase; Cholinergic Agents; Cholinergic Fibers; Electric Stimulation; Hippocampus; Immunotoxins; Male; N-Glycosyl Hydrolases; Neurons, Afferent; Neurotoxins; Nicotine; Nicotinic Agonists; Norepinephrine; Organ Culture Techniques; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Long-Evans; Ribosome Inactivating Proteins, Type 1; Saporins; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 2003 |